Boston Scientific Corp (BSX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Boston Scientific Corp (BSX) has a cash flow conversion efficiency ratio of 0.013x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($348.00 Million) by net assets ($26.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Boston Scientific Corp market capitalisation for the company's overall valuation and market capitalisation.
Boston Scientific Corp - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Boston Scientific Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Boston Scientific Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Boston Scientific Corp ranked by their cash flow conversion efficiency. Explore how high is Boston Scientific Corp's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
National Grid plc
F:NNGD
|
0.033x |
|
Vinci S.A.
PA:DG
|
0.276x |
|
Datadog Inc
NASDAQ:DDOG
|
0.072x |
|
Bajaj Finance Limited
NSE:BAJFINANCE
|
-0.253x |
|
Royal Caribbean Cruises Ltd
NYSE:RCL
|
0.178x |
|
Colgate-Palmolive Company
NYSE:CL
|
1.758x |
|
EOG Resources Inc
NYSE:EOG
|
0.147x |
|
CN YANGT.PWR GDR REG S/A
F:CYZB
|
N/A |
Annual Cash Flow Conversion Efficiency for Boston Scientific Corp (1991–2025)
The table below shows the annual cash flow conversion efficiency of Boston Scientific Corp from 1991 to 2025. View BSX live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $24.47 Billion | $4.53 Billion | 0.185x | +18.68% |
| 2024-12-31 | $22.00 Billion | $3.44 Billion | 0.156x | +21.81% |
| 2023-12-31 | $19.53 Billion | $2.50 Billion | 0.128x | +47.60% |
| 2022-12-31 | $17.57 Billion | $1.53 Billion | 0.087x | -22.81% |
| 2021-12-31 | $16.62 Billion | $1.87 Billion | 0.112x | +14.34% |
| 2020-12-31 | $15.33 Billion | $1.51 Billion | 0.098x | -25.64% |
| 2019-12-31 | $13.88 Billion | $1.84 Billion | 0.132x | +272.38% |
| 2018-12-31 | $8.72 Billion | $310.00 Million | 0.036x | -82.53% |
| 2017-12-31 | $7.01 Billion | $1.43 Billion | 0.203x | +40.89% |
| 2016-12-31 | $6.73 Billion | $972.00 Million | 0.144x | +52.06% |
| 2015-12-31 | $6.32 Billion | $600.00 Million | 0.095x | -48.81% |
| 2014-12-31 | $6.84 Billion | $1.27 Billion | 0.185x | +12.07% |
| 2013-12-31 | $6.54 Billion | $1.08 Billion | 0.165x | -9.78% |
| 2012-12-31 | $6.87 Billion | $1.26 Billion | 0.183x | +106.57% |
| 2011-12-31 | $11.35 Billion | $1.01 Billion | 0.089x | +208.60% |
| 2010-12-31 | $11.30 Billion | $325.00 Million | 0.029x | -57.61% |
| 2009-12-31 | $12.30 Billion | $835.00 Million | 0.068x | -26.66% |
| 2008-12-31 | $13.14 Billion | $1.22 Billion | 0.093x | +49.61% |
| 2007-12-31 | $15.10 Billion | $934.00 Million | 0.062x | -48.70% |
| 2006-12-31 | $15.30 Billion | $1.84 Billion | 0.121x | -42.81% |
| 2005-12-31 | $4.28 Billion | $903.00 Million | 0.211x | -52.95% |
| 2004-12-31 | $4.03 Billion | $1.80 Billion | 0.448x | +62.99% |
| 2003-12-31 | $2.86 Billion | $787.00 Million | 0.275x | -7.83% |
| 2002-12-31 | $2.47 Billion | $736.00 Million | 0.298x | +22.68% |
| 2001-12-31 | $2.02 Billion | $490.00 Million | 0.243x | -36.33% |
| 2000-12-31 | $1.94 Billion | $739.00 Million | 0.382x | -9.43% |
| 1999-12-31 | $1.72 Billion | $727.00 Million | 0.422x | +33.95% |
| 1998-12-31 | $821.10 Million | $258.50 Million | 0.315x | +285.69% |
| 1997-12-31 | $986.20 Million | $80.50 Million | 0.082x | -44.31% |
| 1996-12-31 | $916.30 Million | $134.30 Million | 0.147x | +341.46% |
| 1995-12-31 | $753.00 Million | $25.00 Million | 0.033x | -83.35% |
| 1994-12-31 | $340.00 Million | $67.80 Million | 0.199x | -25.24% |
| 1993-12-31 | $246.70 Million | $65.80 Million | 0.267x | +56.33% |
| 1992-12-31 | $249.10 Million | $42.50 Million | 0.171x | -47.95% |
| 1991-12-31 | $90.30 Million | $29.60 Million | 0.328x | -- |
About Boston Scientific Corp
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyG… Read more